Multiple myeloma is an incurable cancer of bone marrow plasma cells with a median overall survival of 5 years. With newly approved drugs to treat this disease over the last decade, physicians are afforded more opportunities to tailor treatment to individual patients and thereby improve survival...

Healthcare reimbursements in the US have been traditionally based upon a fee-for-service (FFS) scheme, providing incentives for high volume of care, rather than efficient care. The new healthcare legislation tests new payment models that remove such incentives, such as the bundled payment (BP)...

Governments across the world constantly use a variety of measures to contain drug costs in order to increase patient access to critical medications. External Reference Pricing (ERP), or international price comparison, is a commonly employed policy to control prices of pharmaceuticals. ERP uses...